xylonidine

alpha adrenoreceptor stimulation by above cpd mainly inhibits the release of mediator and/or the bronchoconstriction caused by moderate activation of sensory nerves; forced molting agent; structure given in first source

Also Known As:

2-(2,6-dimethylanilino)-2-imidazoline; 2-(2,6-dimethylphenylimino)imidazoline; 2-(2,6-xylylimino)imidazoline; SK&F 35866; SK&F 35886; SK&F-35866; SKF 35866; SKF-35886; xylonidine monohydrochloride

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - xylonidine: 1

Related Diseases

1.	Lethargy 04/01/1989 - "SK&F 35886 (500 micrograms/kg p.o.) did not alter hexobarbital sleep time or elicit piloerection or lethargy, whereas clonidine (37.3 micrograms/kg p.o.) significantly enhanced hexobarbital sleep time. "
2.	Diarrhea 04/01/1989 - "In cecectomized rats, SK&F 35886 abolishes PGE2-induced diarrhea within 1 hr after oral administration of the drug. "

Related Drugs and Biologics

1.	Hexobarbital (Hexenal)
2.	Clonidine (ST 155)

Related Therapies and Procedures

1.	Oral Administration